Skip to content

Clinical trials

Completed Phase 3 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 3 Status: Completed Clear all

94 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20015
20025
20036
200412
200511
200612
20072
20085
20091
20104
20134
20141
20154
20163
20173
20181
20191
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.9
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Janssen, LP6
Corcept Therapeutics5
AstraZeneca4
Organon and Co3
Sumitomo Pharma America, Inc.3
ACADIA Pharmaceuticals Inc.2
Alkermes, Inc.2
BioXcel Therapeutics Inc2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders94
Schizophrenia67
Bipolar Disorder12
Major Depressive Disorder11
Mental Disorders11
Mania5
Psychomotor Agitation4
Alzheimer Disease3
Anxiety Disorders2
Dementia2

Trials

Showing 1 to 25 of 94. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.